Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL715455 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL4216582 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| Ammonia Solution, Strong SCHEMBL193691 | 0.98 | TRPV1 (0.30) | TRPV1TRPA1 | |
| SCHEMBL3347880 | 0.86 | — | — | |
| SCHEMBL7717588 | 0.80 | TRPV1 (0.33) | TRPV1TRPA1 | |
| SCHEMBL642172 | 0.80 | TRPV1 (0.33) | TRPV1TRPA1 | |
| SCHEMBL4335354 | 0.80 | TRPV1 (0.33) | TRPV1TRPA1 | |
| SCHEMBL29750552 | 0.79 | — | — | |
| SCHEMBL29750617 | 0.79 | — | — | |
| SCHEMBL29750521 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114829445-B | Gap filling adhesive | 3M创新有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-114829445-B | Gap filling adhesive | 3M创新有限公司 | 2025-06-10 | — | — | CN | disclosed |
| US-20130109581-A1 | POSITIVELY CHARGED SPECIES AS BINDING REAGENTS IN THE SEPARATION OF PROTEIN AGGREGATES FROM MONOMERS | NOVARTIS AG (CH) | 2013-05-02 | — | — | US | disclosed |
| EP-2496947-A1 | POSITIVELY CHARGED SPECIES AS BINDING REAGENTS IN THE SEPARATION OF PROTEIN AGGREGATES FROM MONOMERS | Novartis AG (CH) | 2012-09-12 | — | — | EP | disclosed |
| WO-2011057029-A1 | POSITIVELY CHARGED SPECIES AS BINDING REAGENTS IN THE SEPARATION OF PROTEIN AGGREGATES FROM MONOMERS | NOVARTIS AG (CH) | 2011-05-12 | — | — | WO | disclosed |